Integrated internist - Addiction medicine - Hepatology model for hepatitis C management for individuals on methadone maintenance

Journal of Viral Hepatitis

Volumn 19, Issue 1, 2012, Pages 47-54

  Martinez, A D ^a   Dimova, R ^b   Marks, K M ^c   Beeder, A B ^d   Zeremski, M ^b   Kreek, M J ^e   Talal, A H ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Center for the Study of Hepatitis C   (United States)

^c Division of Infectious Diseases   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

HCV HIV coinfection; methadone; opiate replacement; substance abuse; viral hepatitis

Indexed keywords

HEPATITIS C ANTIBODY; METHADONE; VIRUS RNA;

ADDICTION; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER DISEASE; LIVER HISTOLOGY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERAPY EFFECT; VIREMIA;

ADULT; ANTIVIRAL AGENTS; BEHAVIOR, ADDICTIVE; DISEASE MANAGEMENT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RNA, VIRAL; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84255162578     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01411.x     Document Type: Article

References (30)

1. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982.
2. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965. (Pubitemid 32913521)
3. Morrill JA, Shrestha M, Grant RW,. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 2005; 20: 754-758. (Pubitemid 41141009)
4. Mehta SH, Genberg BL, Astemborski J, et al. Limited uptake of hepatitis C treatment among injection drug users. J Community Health 2008; 33: 126-133.
5. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW,. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010; 138: 513-521.
6. Volk ML, Tocco R, Saini S, Lok AS,. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology 2009; 50: 1750-1755.
7. Novick DM, Kreek MJ,. Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addiction 2008; 103: 905-918. (Pubitemid 351703476)
8. Ghany MG, Strader DB, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
9. Laine C, Hauck WW, Gourevitch MN, Rothman J, Cohen A, Turner BJ,. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA 2001; 285: 2355-2362. (Pubitemid 32424104)
10. Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y,. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 2001; 286: 1715-1723. (Pubitemid 33010257)
11. del Rio M, Mino A, Perneger TV,. Predictors of patient retention in a newly established methadone maintenance treatment programme. Addiction 1997; 92: 1353-1360. (Pubitemid 27470125)
12. Grebely J, Petoumenos K, Matthews GV, et al. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: the ATAHC Study. Drug Alcohol Depend 2010; 107: 244-249.
13. Broers B, Helbling B, Francois A, et al. Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C. J Hepatol 2005; 42: 323-328. (Pubitemid 40254245)
14. Cheruvu S, Beeder AB, Carden M, Edlin BR, Talal AH,. Strategies to Control Hepatitis C Infection among Injection Drug Users. In:, Negro F, ed. Hot Topics in Viral Hepatitis. Modena, Italy: FB Communications, 2007: 23-30.
15. Merzel C, Moon-Howard J,. Access to health services in an urban community: does source of care make a difference? J Urban Health 2002; 79: 186-199. (Pubitemid 34569099)
16. Strathdee SA, Latka M, Campbell J, et al. Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis 2005; 40 (Suppl. 5): S304-S312. (Pubitemid 40490216)
17. Altice FL, Mostashari F, Friedland GH,. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28: 47-58. (Pubitemid 33104527)
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, revised edn. Washington, DC: American Psychiatric Association, 1994.
19. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002-June 10-12, 2002. Hepatology 2002; 36: S3-S20.
20. Strader DB, Wright T, Thomas DL, Seeff LB,. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-1171. (Pubitemid 38428955)
21. Scheuer PJ,. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374.
22. Sylvestre DL, Clements BJ,. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol 2007; 19: 741-747. (Pubitemid 47266701)
23. Belfiori B, Ciliegi P, Chiodera A, et al. Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy. Dig Liver Dis 2009; 41: 303-307.
24. Litwin AH, Harris KA Jr, Nahvi S, et al. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat 2009; 37: 32-40.
25. Mauss S, Berger F, Goelz J, Jacob B, Schmutz G,. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology 2004; 40: 120-124. (Pubitemid 38868930)
26. Hellard M, Sacks-Davis R, Gold J,. Hepatitis C treatment for injection drug users: a review of the available evidence. Clin Infect Dis 2009; 49: 561-573.
27. Backmund M, Meyer K, Edlin BR,. Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users. Clin Infect Dis 2004; 39: 1540-1543. (Pubitemid 39518222)
28. Dalgard O,. Follow-up studies of treatment for hepatitis C virus infection among injection drug users. Clin Infect Dis 2005; 40 (Suppl. 5): S336-S338. (Pubitemid 40490221)
29. Senn O, Seidenberg A, Rosemann T,. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting. Addiction 2009; 104: 2033-2038.
30. Stein MD, Maksad J, Clarke J,. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 2001; 61: 211-215. (Pubitemid 32119301)